Texts and patches aim to help HIV patients kick the habit

NCT ID NCT05746442

First seen Oct 31, 2025 · Last updated Jun 20, 2026 · Updated 25 times

Summary

This study tests whether a smartphone program that sends personalized text messages, along with nicotine patches, can help people with HIV who smoke to quit. Researchers will enroll 800 smokers in Cambodia and track their progress over 6 months. The goal is to find a simple, low-cost way to reduce smoking in this high-risk group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National AIDS Authority

    RECRUITING

    Phnom Penh, Cambodia

    Contact

    Contact

  • National Center for HIV/AIDS, Dermatology and STD

    RECRUITING

    Phnom Penh, Cambodia

    Contact

    Contact

  • National Institute of Public Health

    RECRUITING

    Phnom Penh, Cambodia

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nicotine patch

What this could lead to

If successful, this could provide an effective, scalable way to help people with HIV quit smoking, improving their overall health.

What could go wrong

This is a behavioral intervention trial; results depend on participant engagement and may not generalize to other populations. Smoking relapse is common.

Conditions

The condition(s) this trial relates to.

HIV infectious disease Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.